Showing results (371-380 of 452) with videos related to
Sort By:
Pageof 46
Current Radiopharmaceuticals|May 1, 2020
Polymer Coated Iron Nanoparticles: Radiolabeling & In vitro StudiesSelin Yilmaz, Cigdem Ichedef, Kadriye Buşra Karatay, et al.Current Radiopharmaceuticals|May 8, 2018
An Overview of Targeted Alpha Therapy with 225Actinium and 213BismuthAlfred Morgenstern, Christos Apostolidis, Clemens Kratochwil, et al.Current Radiopharmaceuticals|September 6, 2016
Brain Network Underlying the Improvement of Social Functioning in Schizophrenic Patients After One-year Treatment with Social Skills TrainingStelvio Sestini, Rosanna Perone, Sandro Domenichetti, et al.Current Radiopharmaceuticals|March 16, 2010
Radioimmunotherapy of infection with Bi-labeled antibodiesEkaterina DadachovaCurrent Radiopharmaceuticals|May 26, 2018
Clinical Studies with Bismuth-213 and Actinium-225 for Hematologic MalignanciesJoseph G JurcicCurrent Radiopharmaceuticals|May 29, 2018
PET Evaluation of Late Cerebral Effect in Advanced Radiation Therapy Techniques for Cranial Base TumorsPierpaolo Alongi, Leonardo Iaccarino, Marco Losa, et al.Current Radiopharmaceuticals|May 29, 2018
Radioprotective Effect of Cerium Oxide Nanoparticles Against Genotoxicity Induced by Ionizing Radiation on Human LymphocytesZohreh Zal, Arash Ghasemi, Shima Azizi, et al.Current Radiopharmaceuticals|April 21, 2018
Motion Management in PET/CT: Technological SolutionsElena De Ponti, Sabrina Morzenti, Cinzia Crivellaro, et al.Current Radiopharmaceuticals|July 7, 2017
Radiochemical Evaluation and In Vitro Assessment of the Targeting Ability of a Novel 99mTc-HYNIC-RGD for U87MG Human Brain Cancer CellsHanieh Karimi, Nourollah Sadeghzadeh, Saeid Abediankenari, et al.Current Radiopharmaceuticals|April 14, 2018
Modeling of a Cyclotron Target for the Production of 11C with Geant4Andrea Chiappiniello, Federico Zagni, Angelo Infantino, et al.Pageof 46